Huntleigh Advisors, Inc.

Position in GH — Guardant Health, Inc.

CIK 1367653 ST. LOUIS, MO

Position in GH

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$456,241

New position

Shares Held

3,041

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#376

of 594 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Huntleigh Advisors, Inc. holds $7,935,528 across 5 Diagnostics & Research names. GH ranks #4 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	12,210	$3,314,404
2	DHR	Danaher Corp /De/	13,874	$2,642,719
3	VCYT	Veracyte, Inc.	25,918	$1,522,164
4	GH	Guardant Health, Inc. This page	3,041	$456,241
5	ADPT	Adaptive Biotechnologies Corp	23,293	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$456,241	3,041	—	Shares	Sole	2026-08-04
No filing history on record for this holder in this stock.